Economy & BankingArticle 13 of 16

Sun Pharma Acquires Organon in $11.75 Billion Deal

· 5 min read
Back to Tuesday

Sun Pharmaceutical Industries, India's largest pharma company, announced the acquisition of Organon & Co — a US-based global healthcare company — for $11.75 billion, making it the largest acquisition ever by an Indian pharmaceutical firm. Organon was spun off from Merck (MSD) in 2021 and specialises in women's health, biosimilars, and established branded medicines. The deal will significantly expand Sun Pharma's global commercial footprint and diversify its portfolio beyond generics.

Key Facts & Details

10 points
  • 1
    Sun Pharma acquires Organon & Co for $11.75 billion — India's largest pharma acquisition
  • 2
    Organon was spun off from Merck (MSD) in 2021
  • 3
    Deal adds women's health, biosimilars, and established brands to Sun Pharma's portfolio
  • 4
    Acquisition will expand Sun Pharma's presence in US, Europe, and emerging markets
  • 5
    Sun Pharma is India's largest pharmaceutical company by revenue
  • 6
    Key challenge: integration and managing significant debt from the acquisition

Deep Dive

  • +
    Organon operates in over 140 countries with a team of 9,000+ employees
  • +
    The acquisition is expected to nearly double Sun Pharma's revenue base
  • +
    Biosimilars market is one of the fastest-growing segments in global pharma
  • +
    Sun Pharma's founder Dilip Shanghvi built the company from a small Kolkata-based trader to a global pharma giant
Q

Exam Focus

Likely MCQ: Sun Pharma's acquisition of Organon at $11.75 billion is the largest acquisition by which sector? Answer: Indian pharmaceutical sector

Related Topics

Mergers & AcquisitionsPharmaceutical sectorIndia business

Exam Relevance & Angle

Economy & Banking, Science & Technology: Large cross-border acquisitions, pharmaceutical sector growth, and India's global business expansion are relevant for Banking and UPSC exams.

Target Exams

SBI POIBPS POUPSC CSESSC CGLRBI Grade B

Background & Context

Sun Pharmaceutical Industries, founded by Dilip Shanghvi in 1983, is India's largest and the world's fourth-largest specialty generic pharmaceutical company by revenue.

Organon was created as a spin-off from Merck & Co (known as MSD outside the US) in June 2021. It focuses on women's health products, biosimilars, and established branded medicines across more than 140 markets.

Related GK Concepts

Must Know
Pharmaceutical industryBiosimilarsMergers & AcquisitionsOrganonSun PharmaWomen's Health

Test Yourself

1 / 3

Sun Pharma's acquisition of Organon & Co in 2026 is valued at approximately how much?

This topic is important for:

SBI PO

Exam Guide Mock Test

IBPS PO

Exam Guide Mock Test

UPSC CSE

Exam Guide Mock Test
Sun Pharma Acquires Organon in $11.75 Billion Deal — Current Affairs 2026-04-28